Literature DB >> 30991389

Assessing Cerebral Metabolism in the Immature Rodent: From Extracts to Real-Time Assessments.

Alkisti Mikrogeorgiou1, Duan Xu2, Donna M Ferriero1,3, Susan J Vannucci4.   

Abstract

Brain development is an energy-expensive process. Although glucose is irreplaceable, the developing brain utilizes a variety of substrates such as lactate and the ketone bodies, β-hydroxybutyrate and acetoacetate, to produce energy and synthesize the structural components necessary for cerebral maturation. When oxygen and nutrient supplies to the brain are restricted, as in neonatal hypoxia-ischemia (HI), cerebral energy metabolism undergoes alterations in substrate use to preserve the production of adenosine triphosphate. These changes have been studied by in situ biochemical methods that yielded valuable quantitative information about high-energy and glycolytic metabolites and established a temporal profile of the cerebral metabolic response to hypoxia and HI. However, these analyses relied on terminal experiments and averaging values from several animals at each time point as well as challenging requirements for accurate tissue processing.More recent methodologies have focused on in vivo longitudinal analyses in individual animals. The emerging field of metabolomics provides a new investigative tool for studying cerebral metabolism. Magnetic resonance spectroscopy (MRS) has enabled the acquisition of a snapshot of the metabolic status of the brain as quantifiable spectra of various intracellular metabolites. Proton (1H) MRS has been used extensively as an experimental and diagnostic tool of HI in the pursuit of markers of long-term neurodevelopmental outcomes. Still, the interpretation of the metabolite spectra acquired with 1H MRS has proven challenging, due to discrepancies among studies, regarding calculations and timing of measurements. As a result, the predictive utility of such studies is not clear. 13C MRS is methodologically more challenging, but it provides a unique window on living tissue metabolism via measurements of the incorporation of 13C label from substrates into brain metabolites and the localized determination of various metabolic fluxes. The newly developed hyperpolarized 13C MRS is an exciting method for assessing cerebral metabolism in vivo, that bears the advantages of conventional 13C MRS but with a huge gain in signal intensity and much shorter acquisition times. The first part of this review article provides a brief description of the findings of biochemical and imaging methods over the years as well as a discussion of their associated strengths and pitfalls. The second part summarizes the current knowledge on cerebral metabolism during development and HI brain injury.
© 2019 S. Karger AG, Basel.

Entities:  

Keywords:  Glucose; Hyperpolarized pyruvate; Lactate; Magnetic resonance spectroscopy; Metabolomics; Neonatal hypoxia ischemia; Vannucci model

Year:  2019        PMID: 30991389      PMCID: PMC6658338          DOI: 10.1159/000496921

Source DB:  PubMed          Journal:  Dev Neurosci        ISSN: 0378-5866            Impact factor:   2.984


  91 in total

Review 1.  Glucose metabolism in the developing brain.

Authors:  R C Vannucci; S J Vannucci
Journal:  Semin Perinatol       Date:  2000-04       Impact factor: 3.300

2.  Carbohydrate and energy metabolism in perinatal rat brain: relation to survival in anoxia.

Authors:  T E Duffy; S J Kohle; R C Vannucci
Journal:  J Neurochem       Date:  1975-02       Impact factor: 5.372

3.  Early brain proton magnetic resonance spectroscopy and neonatal neurology related to neurodevelopmental outcome at 1 year in term infants after presumed hypoxic-ischaemic brain injury.

Authors:  P N Amess; J Penrice; M Wylezinska; A Lorek; J Townsend; J S Wyatt; C Amiel-Tison; E B Cady; A Stewart
Journal:  Dev Med Child Neurol       Date:  1999-07       Impact factor: 5.449

4.  Diet-induced ketosis increases monocarboxylate transporter (MCT1) levels in rat brain.

Authors:  R L Leino; D Z Gerhart; R Duelli; B E Enerson; L R Drewes
Journal:  Neurochem Int       Date:  2001-05       Impact factor: 3.921

5.  Magnetic resonance spectroscopy in neonatal hypoxic-ischaemic insults.

Authors:  E B Cady
Journal:  Childs Nerv Syst       Date:  2001-02       Impact factor: 1.475

6.  Metabolite changes in neonatal rat brain during and after cerebral hypoxia-ischemia: a magnetic resonance spectroscopic imaging study.

Authors:  K L Malisza; P Kozlowski; G Ning; S Bascaramurty; U I Tuor
Journal:  NMR Biomed       Date:  1999-02       Impact factor: 4.044

Review 7.  N-Acetylaspartylglutamate: the most abundant peptide neurotransmitter in the mammalian central nervous system.

Authors:  J H Neale; T Bzdega; B Wroblewska
Journal:  J Neurochem       Date:  2000-08       Impact factor: 5.372

8.  Proton spectroscopy and diffusion imaging on the first day of life after perinatal asphyxia: preliminary report.

Authors:  A J Barkovich; K D Westmark; H S Bedi; J C Partridge; D M Ferriero; D B Vigneron
Journal:  AJNR Am J Neuroradiol       Date:  2001-10       Impact factor: 3.825

9.  Proton MR spectroscopy for the evaluation of brain injury in asphyxiated, term neonates.

Authors:  A J Barkovich; K Baranski; D Vigneron; J C Partridge; D K Hallam; B L Hajnal; D M Ferriero
Journal:  AJNR Am J Neuroradiol       Date:  1999-09       Impact factor: 3.825

10.  Monocarboxylate transporter (MCT1) abundance in brains of suckling and adult rats: a quantitative electron microscopic immunogold study.

Authors:  R L Leino; D Z Gerhart; L R Drewes
Journal:  Brain Res Dev Brain Res       Date:  1999-03-12
View more
  1 in total

1.  Defining Longer-Term Outcomes in an Ovine Model of Moderate Perinatal Hypoxia-Ischemia.

Authors:  Jana Krystofova Mike; Katherine Y Wu; Yasmine White; Praneeti Pathipati; Blaise Ndjamen; Rachel S Hutchings; Courtney Losser; Christian Vento; Kimberly Arellano; Oona Vanhatalo; Samuel Ostrin; Christine Windsor; Janica Ha; Ziad Alhassen; Brian D Goudy; Payam Vali; Satyan Lakshminrusimha; Jogarao V S Gobburu; Janel Long-Boyle; Peggy Chen; Yvonne W Wu; Jeffrey R Fineman; Donna M Ferriero; Emin Maltepe
Journal:  Dev Neurosci       Date:  2022-05-19       Impact factor: 3.421

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.